ArticleFrontiers in pharmacology2026

Value-based pricing of brensocatib for frequently exacerbating non-cystic fibrosis bronchiectasis in China: a China-adapted, FEV

Dandan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.